-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, A1/hhugbtO65VrZ9onWQfI7KdKPQ8SHxETCAhgJFuoUQEfnsb1Z3rQPAmgd0g+DR +DZ7c9wNzILwcESLRXr59A== 0001071739-10-000003.txt : 20100114 0001071739-10-000003.hdr.sgml : 20100114 20100113175901 ACCESSION NUMBER: 0001071739-10-000003 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20100108 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20100114 DATE AS OF CHANGE: 20100113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 041406317 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 10526052 BUSINESS ADDRESS: STREET 1: 7711 CARONDELET AVE CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7711 CARONDELET AVE STREET 2: SUITE 800 CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 form8k.htm FORM 8-K form8k.htm



 
 
UNITED STATES
 
 
SECURITIES AND EXCHANGE COMMISSION
 
 
Washington, D.C. 20549
 
 
 


 
FORM 8-K
 

 
 

 
 
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
Date of report (Date of earliest event reported): January 8, 2010
 
CENTENE CORPORATION
 
 
(Exact name of registrant as specified in its charter)
 
         
Delaware
(State or other jurisdiction of incorporation)
 
001-31826
(Commission file number)
 
42-1406317
(IRS Employer Identification No.)
 
7711 Carondelet Avenue, St. Louis, Missouri 63105
 
 
(Address of principal executive office and zip code)
 
 
Registrant’s telephone number, including area code: (314) 725-4477
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
o
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
o
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
o
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
 


 
 
 
 
 
 
 
 

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
 
On January 8, 2010, the Company issued a press release announcing its 2010 financial guidance.  The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the website cited in the press release is not a part of this report.

The information contained in this Form 8-K and exhibit 99.1 attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section. Nor shall such information or exhibit be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing.
 
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
 
(d) Exhibits.

The following exhibit relating to Item 2.02 shall be deemed to be furnished and not filed:
 
99.1 Press release of Centene Corporation issued January 8, 2010.
 
 
 
 
 
 
 

 
 

 
SIGNATURE
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
         
Date: January 14, 2010
CENTENE CORPORATION
 
 
By:
/s/ William N. Scheffel   
   
William N. Scheffel
 
   
Executive Vice President, Chief Financial Officer and Treasurer
 
 
 
 
 
 
 

 
 

 
EXHIBIT INDEX
 
     
Exhibit
   
Number
 
Description
99.1
 
Press release* of Centene Corporation issued January 8, 2010.
 

 
*The press release is being furnished pursuant to Item 2.02, and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange of 1934, as amended.
 

 

 
EX-99.1 2 exhibit991.htm PRESS RELEASE exhibit991.htm
Exhibit 99.1
 
 

Contact:                 Investor Relations Inquiries:
Edmund E. Kroll, Jr.
Senior Vice President, Finance & Investor Relations
(212) 759-0382

Media Relations Inquiries:
Deanne Lane
Senior Director, Media Affairs
(314) 725-4477

FOR IMMEDIATE RELEASE

CENTENE CORPORATION ANNOUNCES
2010 FINANCIAL GUIDANCE

ST. LOUIS, MISSOURI (January 8, 2010)—Centene Corporation (NYSE: CNC) announced today its 2010 financial guidance. As previously disclosed in our December 10, 2009 press release, the discussions below reflect anticipated start-up costs associated with the new Mississippi contract, announced pharmacy carve-outs in Indiana and Ohio, and the impact of January 2010 rate changes; but do not reflect the potential impact of federal healthcare reform.  In addition, as a result of the Company’s previously announced agreement to sell certain assets of its New Jersey health plan, University Health Plans, Inc., the New Jersey operations are classified as discontinued operations and have been excluded from the guidance provided. All discussions below are in the context of continuing operations, unless otherwise stated.

For its 2010 fiscal year, the Company expects:

·  
Premium and Service revenue in the range of $4.35 billion to $4.45 billion.

·  
Earnings per diluted share of approximately $1.90 to $2.00.

·  
Consolidated Health Benefits Ratio, net of premium taxes, of approximately 84% to 86% which reflects membership mix changes, the previously-mentioned drug carve-outs, and the rate environment.

·  
Higher than normal costs associated with H1N1 and traditional flu strains.

·  
Consolidated G&A expense ratio in the range of 12.4% to 12.9%, net of premium taxes.

·  
Effective tax rate of approximately 37% and diluted shares outstanding of approximately 45 million.

·  
Days in claims payable between 45 and 50 days reflecting the inclusion of pharmacy claims payable (which was not included in prior periods), offset by faster claims processing as a result of operational improvements.

Centene reaffirms its 2009 financial guidance in the previously announced ranges. Full year 2009 earnings will be reported on February 9th, 2010, with the conference call at 8:30 AM (Eastern Time).

Centene will host a conference call today at 8:30 AM (Eastern Time) to discuss the details of its guidance.  Michael F. Neidorff, Chairman and Chief Executive Officer, and William N. Scheffel, Executive Vice President, Chief Financial Officer and Treasurer, of Centene Corporation will lead the call.

Investors and other interested parties are invited to listen to the conference call by dialing 800-273-1254 in the U.S. and Canada, 973-638-3440 from abroad, or via a live Internet broadcast on the Company's website at www.centene.com, under the Investor Relations section.

A replay will be available for on-demand listening shortly after the completion of the call until 11:59 PM (Eastern Time) on January 22, 2010, at the aforementioned URL, or by dialing 800-642-1687 in the U.S. and Canada, or 706-645-9291 from abroad, and entering access code 45124123.

About Centene Corporation
Centene Corporation is a leading multi-line healthcare enterprise that provides programs and related services to individuals receiving benefits under Medicaid, including the Children’s Health Insurance Program (CHIP), as well as Aged, Blind, or Disabled (ABD), Foster Care, Long-Term Care and Medicare (Special Needs Plans).  The Company operates local health plans and offers a range of health insurance solutions to individuals and the rising number of uninsured Americans.  It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, life and health management, managed vision,  telehealth services, pharmacy benefits management and medication adherence. Information regarding Centene is available via the Internet at www.centene.com.

The information provided in this press release contains forward-looking statements that relate to future events and future financial performance of Centene. Subsequent events and developments may cause the Company's estimates to change. The Company disclaims any obligation to update this forward-looking financial information in the future. Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Actual results may differ from projections or estimates due to a variety of important factors, including Centene's ability to accurately predict and effectively manage health benefits and other operating expenses, competition, changes in healthcare practices, changes in federal or state laws or regulations, inflation, provider contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare. The expiration, cancellation or suspension of Centene's Medicaid Managed Care contracts by state governments would also negatively affect Centene.

###
GRAPHIC 3 graphic.gif GRAPHIC begin 644 graphic.gif M1TE&.#EA]P`]`/<``````(````"``("`````@(``@`"`@+^_P,#RE!;C$T:S$Q=3`Z8C([S(]@"]`;3`_?CD\>SDYA#M%7#E# M9S5&=3E#@#I(:SM*@CE*C#M2ACQD-)A$)09D%/=$)1 MA4%65M MC&1JEF)JFV%OH6-VE6%SGV=UHVIG;VMGFVMK:VILE&IPG6YXJ&R+I7-S7EYJ[-O6W=[>WMSY^CG[.KL M].KO\^SJ\^[N\._Q]>_W__7R^/?O__CX^/K\_/[^_O_[\)^?GWU]??\```#_ M`/__````__\`_P#______R'Y!```````+`````#W`#T`AP```(````"``("` M````@(``@`"`@+^_P,#RE!;C$T:S$Q=3`Z8C([S(]@"]`;3`_?CD\>SDYA#M%7#E#9S5&=3E#@#I(:SM*@CE*C#M2ACQD-)A$)09D%/=$)1A4%65MC&1JEF)JFV%OH6-VE6%SGV=UHVIG;VMG MFVMK:VILE&IPG6YXJ&R+I7-S7EYJ[-O6 MW=[>WMSY^CG[.KL].KO\^SJ\^[N\._Q]>_W__7R^/?O__CX M^/K\_/[^_O_[\)^?GWU]??\```#_`/__````__\`_P#______PC^`.L)'$BP MH,&#"!,J7,BPH<.'$"-*G$BQHL6"[Z"]HE6K%D>.M6"9>W>QI,F3*%.J7#E1 MW9D)(&*XB+$"!`P7*%:X*`&"TS:$Q%"]4N7*E:JA15D-)T>4 MJ-&EK^8E=.?T5=.K5H]:5:KJ:5E73/EP8<&/$C1,/?.=.,DM4/QY\`.&A!8H/+CJS`.U! MQ`,9B7X6#*.@0H,($Q94>`";`84'#B;8QEW!]@0'$E#0&^?`-6S9M"78<8

#&`7?QU[]O';M6\7W[U=NG$&E]C^+#AN7;=V\]"],W#PHUZ?(4F0&(EO M!`F1(H3:(204)#[]^$$X4X\B0]1'!'WV(7B@?$D<\1\2`0JD3BY[H**&."S5 MH\H#,[`P`PTH],#""B"*2&*(+*!P0@?$%%3'!")^B**,)I8X8@\H=+C"##_0 M8\Z.'MKX(0,M'B3.#"NL@".-0$$I4C2`9-0C@BBCDM. MB8(4]:3Q``HH;-D!FEL^T`Q"5W"X9IHS=/``,_74<2:='7B09IH>U,FFH"A8 M4.>=4\5YQ2%$W/#-2J-$`$()+;!PPDZ57HJ""I;BQ.D)'W0`#$%J>$!IIZ=J M^JFGG6X*P@C^.]"##J:H9@J"$-H868(*()S@F0JT`ILJK:JV^NFOM#IP2AT? MU&KLLZIBVH$2]831[*7#?I8%0F"8BBRE$TBCS0BK;@JMIYANBND$QM23RR9A M9(%'!C808ME%\[CR@`01CA=.U+%$-ZR0=-(U#X#`@DPT M;3W3"EN3V"%--"!)TP2.)%9'R%US#3;98XN]0M:8_?;^UUN#@`(N M!OVXX]Q[M\VW3%6&73;AB]/]]02N[%%"X6^+K;C>'L[D@1/UE#&YUVV?:$$X M!H7!=N$33$.-!Z&7?3GAF1L>PP3'U+/'-V0@40(G]81BM4EL:":P9]<2SUFE MH/G*@@DXB<#"`J8(-(<&Q%M*O`N^?H8]\CA5:H(*-]!S3F>?65^^KQW(\+M` MY+0``O,H.#\PSM5GGSSW*'C?O,X?8+G'!L73GO+NM[S]S8]S90"@^0CX`0\< MHG0X!#$79!C18X81`]H\@U5K`E$-F` M2BBP@04"Q:8=24E)4JH9AN8P@1?*R`;^7NK`"28P`0_LBXA&]``1.<`"']GP MASEQH<#2L+XCK2"&4L(B%$\$Q!/IR()K'&CJ`C7D08@$) M,PD]",$`=`UK!#D8A3G$P8HCK!%EZ&*`*^I1JF&E"@A_P$,=_J"'5.*!E7^H M`Q[@@`A9$>N6NV)!!J)!$''L:B>6[)<$>E.!W[BF`KUB5;%&,!L)Z&8V"O`$ M(5Z&K4SMY`>O;"4>LED'6:8R#;P+`S5O:2X4>(`&ZR!(MTI@R:5=PQH9L*:Y M-.5,!C3SF0_^J&=OBC2/4*#"%)GH1@HG,@\+`(UD`KL5-PBB#EIX0`5(VLJ" MK[K5=2/@G4`$UZ&NUI6%>CW(&CR`UK_2H`.62,@6/E?8'DQ@$A!9[%W[:KD> M>(`(ZAA(&";GUZ^FSAH32%QA8W"#]66U(:Z8WP(]D(:!JJ%9\)/^WTYZ\0CJ MG8]X'K##1LD7P,W8#WL4J`7[W#[N]T6QO`F#0;`1O2T$+8I"!H6D!5D_[$%IH,44O7,$$*)$0;2AQ MC?M2H@H8P(E)]!"0\?5`'C::(QC&=X\K>.$)G)#9<"#IO3%\`"$2(@<_=?&% M0'Q`)1*RA@UP,2>#]$!@&Z(&MB)XD!?&8@ER5:W_=@B-?O23#2^<1].R5R&S M<,%-U+7C'CP*(>:00A:RX(4M>"$,6^B"%7)A"`_ M`Y730`8\,*<>'&4GE%V0(AUK+64QD,#^+<#LJAT#"P85R.Y!X#!>3J5L4QZ( M*T+$.>8RE^`'5L9R&K0L:"WCP6I>&.>3[VQG3TV`BCYS,KIN,H%W9H#,C$Y1 M3*+QC4Y[^M.=SNR-99%>I5F@!P-MR,(PUC`0/*`"%I#`!1Y`@5C/6E*BYBBK M+\J_%5Q#'2@M-6GBG)`TU-F##9PP0K(@5*-]P`(.F'6M'W!K"Q2-'0()JD>= MRFT&6*,>2"4?R9;:U(C-[W@H1;<'0,"`7MRX'K2@;%WKBH(?V/@A:_OKO,_* M@K-6]HI"$/5<.]MOK_:[K_V>P![4(4A]BZ@#>A8L80]NV`X\$"&2W3?"_%T_&]J-4W8&=>L!"'8$@J[N:`*^>+=#.ZBI M#P#AW@Z9'L^M2W2=N4\&N>;M`JN;P=&`(`WNBVVGD*MG%;=:T*Y/S&[HTO?,U)!*`W M9`X/T#L6$SQX#._=A[D>_-Z3Q*&<&#[!'-K[BVT@X6);.(R!U#"'/;SXQQL> MBT#,R0W$K@;.%WY3C@]D#/^,X+U+(,:IC^_G9Y^3%'G@[NR=!0MN0A,=XT0( M?F>(RQ;M^S+#`&QH!AOO/7"#7!<_93L6@BK\FOPRTV0%O-<)##S^(&>#T)EO MR<]S0O@,?4R#GV_9W\D.Q$[^YX,@%#_P&_IQHOVO^;[2UAB!^;M6_?2G/P/N M-FK(EEX6X`.IQA`+(QH#\S"O9FL3`&NR-@$1L`+.IX#=`P(RT#04P#_(-H`> M@%W%QG;(Y@'*=A#,9G0(-+(PU,930I MD(+7LX+MIG,T,&]6@B,W8`X),0_B(`[FT(1.:`[AX`YK180BT@,T<"M/X`57 M$`5AX`17L(5A$`57$`8"]R15B`(W$`_=4'LQ,H1M2(1#V`'=5Q"+](8Q8G&* MA0(W$B16PDJ:5,CC:'!$$.FS%W/24*CR""V:,"N;51]K-`.I!9 MA!`!W55-SG)<'(,0RZ4\PH)UT740T\4KK8@]'W`%'`$+'I&,'4$+&Q$/`C&, MY@,L&3`,]6`,%C`"UI0MY5)!U(!!P%*,E*(*S.@1(=&,KS!2-T8,'B!X+Z0" M(+#\60F.:.*/!Z M?P0R[ZB0-G#^@.\V$/-@$_;W9#,@?@:!#3NA?%\S-Q,0"I(@:;%#9B.P!QM5 M?#/P-2$B:K_P`(VYS?^\T`F#CE7%I5J(VDPKQ#C7H7:+!/`P0"?0P$.P0#"KP`>5S M@RD0#(7@`:(!&LZE`7J0E(MY@4@G$.\`!80Y09@9&B`(D2+(6R28$">(BB[P M`)$`5+!E0!5PE@+1#4-0`1[(/9U!;K)5F)5R#G:Y$/3085%B(CAR`FMP"S`'.9@A@7^1@-UZ0MG M8HE-$B55"9&/R(=W>'$'<8A[:(G-29W2Z0[N.9W1>9WUD`6(V(99J9H"40L/ M4"5MB")0LE21EXA5TB'!=YOU8`V34B[E(@$6<`(5\#&XE"D>``CUL':>PG3` M@@(Y<`,VH`,ST*$?2@,=&J)((#[%TG.S2).9X)JX^**CN8L'44HC0RM9)UT; M<"SJHCP?&J(>J@,D>@,S`*0ML"W26(P9H`P$,0^3$$'"([;HRZ44@LK MY0LV-556%0R]L%[L108-8#2-%C0JE,V91F5 M6(D"1>(RC,!^LE>M<``)E5` M\>.#Y!4!0`"-]9"`^#.;\E,_U3-1MA29^8.!=;E7Q&6#/[B9!V%L'>29)5@Z MI]FNJJ5TO]49'<`$-\.N\I.:!V$%YY5>>IF#\#2;F+E`PI9>3#.3H[`G8$)( M,+0D7_(`/R#^CWGB)R<;LR62LD'4!!;S)5,R2-QI$*Z0G(`DGJ0X$&GPB"F; M(PX$FB>0LRFBLB%"LU#2`9P3!DF+0R^6K0:!#DU@8@#Z)0(JLTW+)4_"M>UB MEZH@!*;"H)/R+;92`GCP8])S;*HR*>V4BR`P!"@JBN:4IP61!A-@2M;TIY9W M*K_X7(F@=93*:,$RH707J8@:+1E0)`;!"A)P+BNI.N"8ME2ZC?+4C:EJE^5@ M!1T@*063,4HE`3:@"Z73&K111"*C-)S!4^!3IRWP,5EYIWI+$/3(:C(#N!!I M42P`,G":45]F$&7P`/`H;J3K,*_+:A^`0,:;ET+\`G(TZ("O9:%`=T+\3$`/R.Q`O,L#_&\`E\)#(2E=E MI01?8`6?\`F\4`X&X04/T`'_N[_N*\$E+,`F_`!W@+H(2A#H@`W+``4,@@3T,0QW]!#; M<`W:@`U43,56K`W7@`U:K,5[+*!RG8@ M4`5W4`5,``5?H`F:P,&6T0UD7,99C,7^5[S&:SQ2?$S&7:S&PWL0X3#&:RR= M@'S(@=S%UZ`&66`#]!$%0C`,SQ`+L>"E1UP/CA'*?_G),\FW,"D&:-`$:#(! M9%`-GX#'!T#*[^8.R:`)W.`8]2`,BZ`)B^#!LOS+I!R1)9`#D$`%&"!F'*`( M]9`,B[`(]P#,IU4.S;Q0`Z'+>=S`T)S-6;4P,[`(59`S67<`@<`+,JG-%%$- MBX`/_PH.^/`)X&#.\'Q:>C(&?M`!^R9?/\4-O!#/*N$.^.#,_!S0[Q8&/H`) M--!;GWD0^GP/#-W!2WH/O,#0X/`,#)T,RQS1PC`/!Q#1O/`,*00.$=W0OES- M%3T/%'T/&5W^#R;-T"Q]#XF<#*^\P;S0R`!8S0D(.7T`3A#KSP"CP M#&0MU18M(<+`UJ]_=7#BP[_'`L#H0ZXW=G)@%7H8-K$ M70_O70^6_=5U"0YX'-CU4`XQ3)/-^+H.#U M8-R:D-("P0U0_/-_H_=#IG!CE@,?4S%`+C@[JH-K#/1`GGN-&#M4*?MN+P.($ M$0MYO%X'D-L%\>$A#LS/<-D-4"&[W,"PO0B=/1`R[L&U;,L& MP/F6B'67$W5*OW4@>#H MO)`->>WD]0`.4%T-!?'6Y*S2>;W7!L$-N^S+68X/EN'JV[WHLIS6(S-\/YN MT:[<,AGQ]X+^#AJO[=AN$.CLS@5Q`*\5>WQXF!U1C_Y'$N$%D>Z).^R^#NZY]0E^KMZ"UOUE[*[DOJ]-W.RX*^WN6\ M]"SA[DU>#NOL]NAPV5^F#EF^"!Y]]>DLOZ)NZ_C=]9H`ZRV.]J*F#EQ^#XEA MW`8OYJ.NTB.^P>JP7BY.XH7.'%L?G?40^O>P7J+>Y-6Y`=0#V3']#+]O^^]>ZLT<"[G?U3#^WO0.SE!O M_?\`P_WO4^+!N)+IA!< MH$6QYBFL=P#?(H<5P1T(I"D0OG+UY@GC*/#316X4'-5I+H M5&[9<")TE_5B3ZQ1ZZES:E8AU*=KP94]6X^NUI[@^&),RVWK4L*%#1]&G#CI MST^#%3^&'%GR9,J5*?,*:EGS9LZ=/7\:QHB9)VC2I4V?/LWMDR9>J%V_AAU; ']NS'`0$`.S\_ ` end -----END PRIVACY-ENHANCED MESSAGE-----